Precept Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-15,000
Closed -$888K 60
2021
Q4
$888K Hold
15,000
0.35% 40
2021
Q3
$998K Hold
15,000
0.47% 58
2021
Q2
$947K Sell
15,000
-25,000
-63% -$1.41M 0.4% 51
2021
Q1
$2.08M Buy
40,000
+9,500
+31% +$578K 1.42% 23
2020
Q4
$1.34M Hold
30,500
0.54% 34
2020
Q3
$1.45M Hold
30,500
0.35% 47
2020
Q2
$923K Hold
30,500
0.18% 63
2020
Q1
$521K Sell
30,500
-119,500
-80% -$2.09M 0.06% 96
2019
Q4
$2.47M Buy
150,000
+85,000
+131% +$1.26M 1.19% 24
2019
Q3
$1.06M Sell
65,000
-75,000
-54% -$1.5M 0.64% 45
2019
Q2
$2.56M Buy
140,000
+18,202
+15% +$289K 0.8% 25
2019
Q1
$1.57M Buy
+121,798
New +$1.32M 0.71% 37

Other funds holding CYRX

Precept Management's CYRX Position: Q1 2022 in Review

Precept Management sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 15,000 shares — an estimated $888K sold.

Precept Management first reported a position in CYRX in Q1 2019 and held it in 12 quarters. The position peaked at $2.56M in Q2 2019. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.

  • Precept Management reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
  • Precept Management sold 15,000 CryoPort shares in Q1 2022, an estimated $888K.
  • Precept Management first reported a position in CryoPort in Q1 2019 and held it in 12 quarters.
  • Precept Management's CryoPort position peaked at $2.56M in Q2 2019.
  • 200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.

Based on Precept Management's 13F filing for Q1 2022, filed 16 May 2022.